Please enable Javascript
The HemOnc Pulse
Meeting News
The HemOnc Pulse Live
Video Insights
In Print
Subscribe
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Lymphoma
Aggressive B-Cell Lymphoma
Hodgkin Lymphoma
Indolent B-Cell Lymphoma
Mantle Cell Lymphoma
T-Cell Lymphoma
MPN
Myelofibrosis
Polycythemia Vera
MDS
Myeloma
Transplantation & Cellular Therapy
Ola Landgren, MD, PhD
Articles by Ola Landgren, MD, PhD
How Quadruplet Therapy Is Changing the Myeloma Treatment Landscape
Ola Landgren, MD, PhD
Myeloma
|
June 17, 2024
Ola Landgren, MD, PhD, discusses three studies on quadruplet therapy presented at the 2024 ASCO Annual Meeting.
View More
Biology and Therapy of Early Multiple Myeloma: Future Directions
Ola Landgren, MD, PhD
Myeloma
|
August 18, 2021
Differentiation between MGUS and SMM is currently based on indirect measures and surrogate markers of disease burden.
Read More